(888) 552-6760 SCHEDULE AN APPOINTMENT

Tycel Phillips,

M.D.

Hematologist-Oncologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Education
Medical school:
Board Certifications
  • American Board of Internal Medicine-Medical Oncology
  • American Board of Internal Medicine-Hematology
Degrees
  • 2006, Doctor of Medicine, Rush University, Chicago, Illinois
  • 2001, Bachelor of Science, University of Illinois, Urbana-Champaign, Illinois
Fellowship
  • 2012, Fellowship, Hematology and Oncology, University Hospitals, Cleveland, Ohio
Residency
  • 2009, Residency, Internal Medicine, John H. Stroger Hospital of Cook County, Chicago, Illinois
Internship
  • 2007, Internship, Internal Medicine, John H. Stroger Hospital of Cook County, Chicago, Illinois

Professional Experience
  • 2022-present, Associate Professor, Department of Hematology and Hematopoietic Cell Transplantation, Division of Lymphoma, City of Hope, Duarte, California
  • 2021-2022, Maria Reinhardt DeCesare Reserach Professor of Blood Cancers and Bone Marrow Transplantation, Michigan Medicine, Ann Arbor, Michigan
  • 2020-2021, Clinical Associate Professor, Internal Medicine, Hematology/Oncology, University of Michigan-Ann Arbor, Ann Arbor, Michigan
  • 2015-2020, Clinical Assistant Professor, Internal Medicine, Hematology/Oncology, University of Michigan-Ann Arbor, Ann Arbor, Michigan
Memberships
  • 2023-present, Member, European Hematology Association
  • 2022-present, Member, SITC Committee
  • 2021-present, Member, MSHO
  • 2014-present, Member, SWOG
  • 2014-present, Member, Big10 Cancer Research Consortium
  • 2011-present, Member, American Association for Cancer Research
  • 2009-present, Member, American Society of Hematology
  • 2009-present, Member, American Society of Clinical Oncology
  • 2002-2006, Member, Student National Medical Association
Academic Appointments
  • Associate Professor, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation
About Me

Tycel Phillips, M.D., is a hematologist-oncologist at City of Hope® Cancer Center Duarte, where he leads clinical trials designed to support the development of innovative targeted therapies for blood cancers. 

As a teenager, Dr. Phillips witnessed the impact pancreatic cancer had on his grandmother, whose life of service inspired him to pursue a career in medicine. Later, during his medical residency, he experienced the loss of his mother to breast cancer. Her difficult experience with chemotherapy motivated him to focus on developing cancer treatments that are more tolerable and less harmful to patients. In his work with patients, Dr. Phillips believes in listening carefully to fully understand every patient’s concerns and create the most effective and personalized treatment plan for them. 

Dr. Phillips earned his medical degree from Rush University and completed a residency in internal medicine at the John H. Stroger Jr. Hospital of Cook County, both in Chicago. His fellowship in oncology and hematology took place at University Hospitals in Cleveland. Prior to joining City of Hope, he served as a clinical associate professor at the University of Michigan, where he held the title of Maria Reinhardt DeCesare Research Professor of Blood Cancers and Bone Marrow Transplantation. Dr. Phillips has authored or co-written more than 40 peer-reviewed publications and received numerous research grants to support his work. 

Outside of the clinic, Dr. Phillips enjoys reading, traveling and biking with his children.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.